DEF 14AThe Ballot
Spyre Therapeutics, Inc. files DEF 14A
Filed Apr 21, 2017 · 9y ago · Accession 0001564590-17-006805
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- DEF 14A
- Filing date
- Apr 21, 2017
- Report date
- Jun 7, 2017
- Document
- agle-def14a_20170607.htm
- Size
- 1.3 MB